21 results match your criteria: "Psychiatric Hospital of the University of Munich[Affiliation]"
Crim Behav Ment Health
December 2022
Department of Forensic Psychiatry, Psychiatric Hospital of the University of Munich, Munich, Germany.
Brain Behav
May 2019
Department of Psychiatry and Psychotherapy, Otto-von-Guericke University, Magdeburg, Germany.
Objectives: The direct exertion as well as the visual perception of violence can have a hedonistic effect and elicit positive arousal in predisposed individuals. This appetitive aspect of aggression in healthy subjects has been neglected in psychiatric research so far.
Methods: Using functional magnetic resonance imaging, we tested whether subjects trained in sports with a violent component (martial arts) show altered brain responses in reward-associated brain areas when compared to controls.
Psychopharmacology (Berl)
December 2018
Experimental and Clinical Pharmacopsychology, Department of Psychiatry, Psychotherapy, and Psychosomatics, Psychiatric Hospital of the University of Zurich, Lenggstrasse 31, PO Box 1931, 8008, Zurich, Switzerland.
Rationale: Non-medical prescription opioid use (NMPOU) has become a major public health issue in the USA and is also increasing in Europe. However, little is known about neuropsychological associations of NMPOU-specifically regarding social cognition, which is essential for social functioning and treatability of opioid dependence. Previous studies with heroin users and opioid-substituted patients reported deficits in various cognitive functions, but these results are likely confounded by comorbid physical and psychiatric diseases, overdose-associated hypoxia, and adulteration of street heroin.
View Article and Find Full Text PDFEur Neuropsychopharmacol
July 2018
Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Germany. Electronic address:
Pedophilia is a heterogeneous disorder for which the neurobiological correlates are not well established. In particular, there are no biological markers identifying individuals with high risk to commit child sexual offense (CSO). Pedophiles with CSO (P+CSO; N = 73), pedophiles without CSO (P-CSO; N = 77), and non-pedophilic controls (NPC; N = 133) were assessed using multimodal structural neuroimaging measures including: cortical thickness (CT), surface area (SA), and white matter fractional anisotropy (FA), as well as full scale IQ (FSIQ) performance.
View Article and Find Full Text PDFTransl Psychiatry
May 2017
Division of Mind and Brain Research, Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Pedophilia is a psychiatric disorder that is inter-related with but distinct from child sexual offending (CSO). Neural alterations reportedly contribute to both pedophilia and CSO, but until now, no study has distinguished the brain structural anomalies associated with pedophilia from those specifically associated with CSO in pedophilic men. Using high-resolution T1-weighted brain images and voxel-based morphometry, we analyzed the gray matter (GM) volume of the following 219 men recruited at four acquisition sites in Germany: 58 pedophiles with a history of CSO, 60 pedophiles without any history of CSO and 101 non-pedophilic, non-offending controls to control for the effects of age, education level, verbal IQ, sexual orientation and the acquisition site.
View Article and Find Full Text PDFCrim Behav Ment Health
October 2012
Department of Forensic Psychiatry, Psychiatric Hospital of the University of Munich, Nussbaumstr. 7D-80336, Munich, Germany.
Background: Forensic psychiatry was long regarded as sufficiently defined by the laws of a country to be restricted by national boundaries in all but a few areas. European Union (EU) employment rights and travel facilities have changed that within the EU.
Aims: The goal of this research is to explore the role and development of a network of teachers and trainees in forensic psychiatry.
Int Clin Psychopharmacol
March 2008
Psychiatric Hospital of the University of Munich, Munich, Germany.
This double-blind, double-dummy study (D1444C00146) evaluated the efficacy and safety of switching patients with clinically stable schizophrenia from quetiapine immediate release (IR) to the same dose of once-daily extended release quetiapine fumarate (quetiapine XR). Patients received quetiapine IR 400-800 mg/day twice daily for 4 weeks, and were then randomized (2 : 1) to a once-daily equivalent dose of quetiapine XR or maintained on IR for 6 weeks. The primary variable was the proportion of patients who discontinued treatment owing to lack of efficacy or whose Positive and Negative Syndrome Scale scores increased by at least 20% from randomization to any visit.
View Article and Find Full Text PDFEur Arch Psychiatry Clin Neurosci
October 2005
Psychiatric Hospital of the University of Munich, Nussbaumstr. 7, 80336, München, Germany.
We report results of a FDG-PET study in 10 patients with schizophrenia (6 unmedicated, 4 never medicated) and 12 healthy age-matched controls. The patients met ICD-10 and DSM-IV criteria for schizophrenia and all reported psychotic, "positive" symptoms when tested. Schizophrenic patients had higher absolute CMRGlu values in almost all quantified regions compared to normal subjects.
View Article and Find Full Text PDFEur Arch Psychiatry Clin Neurosci
February 2005
Psychiatric Hospital of the University of Munich, Nussbaumstr. 7, 80336 Munich, Germany.
Background: Recently published data might indicate that the polarity of recurrence is related to lithium serum levels. To systematically test this hypothesis all published maintenance trials in bipolar disorders were examined with regard to this issue.
Method: Maintenance studies were subdivided in trials with low (i.
Background: Predicting and preventing premature discontinuation of medication would substantially improve prophylactic treatment of bipolar disorder. Patients' concepts regarding illness proved to have an impact on noncompliance in a retrospective study of patients with affective or schizoaffective illness treated with lithium. The present study is the first to prospectively investigate the influence of illness concepts on adherence of bipolar patients to different medications.
View Article and Find Full Text PDFDialogues Clin Neurosci
March 2004
Psychiatric Hospital of the University of Munich, Munich, Germany.
Treatment-resistance in schizophrenia remains a public health problem: about 20% to 30% of patients do not respond to antipsychotic therapy. Clozapine has been shown to be effective in about one-third of patients, but the medical risks and weekly blood tests limit its broad application. While the heterogeneity of the disease and the duration of untreated psychosis are important, pharmacogenomic aspects must also be considered.
View Article and Find Full Text PDFObjective: Concepts in the treatment of bipolar disorder are discussed considering clinical practice.
Method: Results of the Multicenter Study of Long-term Treatment of Affective and Schizoaffective Psychoses (MAP) study, a controlled maintenance trial, are interpreted with respect to treatment concepts.
Results: The spectrum of patients diagnosed as bipolar has become more heterogeneous.
J Affect Disord
January 2001
Psychiatric Hospital of the University of Munich, Nussbaumstrasse 7, D-80336, Munich, Germany.
New technologies have led to tremendous progress in understanding what today we call bipolar disorders, whose clinical diagnosis has been refined continuously since Kraepelin first described them. Molecular genetic studies have produced interesting findings, but to date have failed to identify specific genes that are so far responsible for the vulnerability to bipolar disorders. Biochemical studies in combination with pharmacotherapy give hints that the neurotransmitter function and the related signal transduction may be abnormally regulated.
View Article and Find Full Text PDFNeuropsychobiology
February 2001
In a randomized clinical trial with an observation period of 2.5 years, the differential efficacy of lithium versus carbamazepine was compared in 171 bipolar patients (DSM-IV). In order to investigate the efficacy of the two drugs in clearly defined subsamples, a series of subgroup analyses was carried out.
View Article and Find Full Text PDFEur Arch Psychiatry Clin Neurosci
October 1999
It has been reported recently that the prophylactic efficacy of lithium is a transient phenomenon in many patients. Other studies suggest sustained efficacy against affective recurrences for many years. As this issue is of major therapeutic relevance, published literature considering changes in lithium efficacy over time has been reviewed.
View Article and Find Full Text PDFJ Clin Psychopharmacol
December 1998
In a randomized, prospective, multicenter study with an observation period of 2.5 years, the differential prophylactic efficacy of lithium versus carbamazepine was compared in 171 patients fulfilling DSM-IV criteria for bipolar disorder. Serum drug levels were 0.
View Article and Find Full Text PDFEur Arch Psychiatry Clin Neurosci
June 1997
In a randomised multicentre study, the prophylactic efficacy of lithium and carbamazepine was compared in schizoaffective disorder. A total of 90 ICD-9 schizoaffective patients were included in the maintenance phase (2.5 years).
View Article and Find Full Text PDFThe present study, including 81 depressive patients, compares the prophylactic efficacy of lithium and amitriptyline in recurrent unipolar depression over a treatment period of 2.5 years in a randomised multicentre design. Hospitalisation, re-emergence of depressive or subdepressive recurrences, unwanted side-effects and need of concomitant psychotropic medication were considered to indicate treatment failures.
View Article and Find Full Text PDFJ Clin Forensic Med
June 1994
Psychiatric Hospital of the University of Munich, Nussbaumstr. 7, 80336 Munich, Germany.
There is increasing evidence that schizophrenics are at a comparatively high risk for delinquency and violent behaviour. There is a need to define risk factors for aggression and violence in schizophrenics. Apart from an apparently higher rate of violent and assaultive behaviour in male schizophrenics, on the psychopathological level, symptoms such as vivid hallucinations or delusions have been proposed as possible risk factors.
View Article and Find Full Text PDFJ Neural Transm Suppl
May 1991
Department of Neurochemistry, Psychiatric Hospital of the University of Munich, Federal Republic of Germany.
The discovery of the clinical efficacy of imipramine and of the MAO-inhibitor iproniazid intensively stimulated biochemical-pharmacological research on the mechanism of action of antidepressants. Due to these investigations, until recently an enhanced activity of the central noradrenergic and/or serotonergic transmitter system was considered essential for the clinical antidepressive action. Such enhancement could be achieved either presynaptically by blocking alpha 2-adrenergic receptors, or in the synaptic cleft by inhibiting the transmitter reuptake or the main metabolic enzyme, MAO.
View Article and Find Full Text PDFIn a retrospective study the case histories of 154 patients with acute alcohol psychosis were examined. The obvious diagnostic criteria in the doctor's differential diagnosis between alcohol withdrawal delirium and alcohol hallucinosis was clouding of sensorium and disorientation. 103 patients were diagnosed as having alcohol withdrawal delirium, 51 patients alcohol hallucinosis.
View Article and Find Full Text PDF